News
2023
September 20, 2023
Brookline Capital Markets Announces Addition of Charles Mather to Investment Banking Team
VIEW PRESS RELEASEJune 28, 2023
Brookline Commends Genelux for Its Recent Issuances
VIEW PRESS RELEASEJune 23, 2023
Calidi Biotherapeutics Receives $25M Series B Commitment Supporting First Light Acquisition Deal
VIEW PRESS RELEASEApril 20, 2023
Brookline Capital Markets' Senior Biotechnology Analyst Kemp Dolliver Discusses Bellerophon Therapeutics and Outlook Therapeutics with Bloomberg BNN
VIEW PRESS RELEASEMarch 17, 2023
Brookline Capital Markets Recognizes the Robust Performance of the Genelux Corporation Initial Public Offering
VIEW PRESS RELEASE2022
November 14, 2022
AGBA Acquisition Limited Completes Business Combination With TAG Holdings Ltd.
VIEW PRESS RELEASEAugust 9, 2022
Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split
VIEW PRESS RELEASEAugust 1, 2022
Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company
VIEW PRESS RELEASEJuly 18, 2022
Brookline Capital Markets Hosts Biotech Symposium Today
VIEW PRESS RELEASEJune 9, 2022
Brookline Capital Markets Announces Strategic Partnership Agreement with Stuart Frankel & Co.
VIEW PRESS RELEASE2021
December 21, 2021
Larkspur Health Acquisition Corp. Prices $75 Million Initial Public Offering
VIEW PRESS RELEASEDecember 15, 2021
Ault Disruptive Technologies Corporation Prices $100 Million Initial Public Offering
VIEW PRESS RELEASEDecember 13, 2021
IceCure Medical LTD. Closes $17 Million Underwritten Public Offering
VIEW PRESS RELEASEDecember 13, 2021
Alpha Star Acquisition Prices $100M IPO
VIEW PRESS RELEASEDecember 08, 2021
Inception Growth Acquisition Limited Announces Pricing of $90,000,000 Initial Public Offering
VIEW PRESS RELEASE2020
December 17, 2020
SCYNEXIS Announces Pricing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
VIEW PRESS RELEASEDecember 16, 2020
BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market
VIEW PRESS RELEASEDecember 14, 2020
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market
VIEW PRESS RELEASEDecember 11, 2020
9 Meters Biopharma, Inc. Prices Public Offering of Common Stock
VIEW PRESS RELEASENovember 12, 2020
InMed Announces Pricing of US $8.0 Million Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM"
VIEW PRESS RELEASE2019
December 23, 2019
Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock
VIEW PRESS RELEASEDecember 12, 2019
SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants
VIEW PRESS RELEASEOctober 22, 2019
Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering
VIEW PRESS RELEASESeptember 26, 2019
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
VIEW PRESS RELEASEAugust 6, 2019
BioCardia Announces Closing of $10.0 Million Public Offering
VIEW PRESS RELEASE
